Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression
M. Royuela et al., Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression, EUR CYTOKIN, 11(1), 2000, pp. 119-127
The therapeutic potential of IFN-gamma in prostatic cancer has been documen
ted in several reports, although no immunohistochemical studies of this fac
tor and its receptors in the prostate have been reported. The aim of the pr
esent study was to investigate the expression of IFN-gamma and its receptor
components (IFN-gamma-R alpha and IFN-gamma-R beta) in normal prostate, be
nign prostatic hyperplasia (BPH) and prostatic cancer (PC), as well as the
possible relationship between this factor and the products of the p53 gene
(the wild and mutant forms) and the oncogene c-myc, by means of immunochemi
cal techniques (Western blot, ELISA, and quantification of immunostaining i
n histological sections). In normal prostate, IFN-gamma and its two recepto
rs were expressed in the basal cells of the epithelium and some stromal cel
ls. In BPH specimens, immunostaining of basal epithelial cells was signific
antly increased for IFN-gamma and its alpha receptor, whereas stromal cell
immunostaining was significantly increased for IFN-gamma and its beta recep
tor. In addition, columnar epithelia; cells immunostained for IFN beta-R be
ta. PC specimens differed from BPH specimens in the significantly increased
immunostaining of epithelial cells for IFN-gamma, and its two receptors, a
nd the immunostaining of columnar epithelial cells for IFN-gamma-R alpha, I
mmunodetection of wild-p53 was weak and limited to some stromal cells in th
e three types of specimens. Immunostainings for both mutant-p53 and c-myc w
ere negative in normal prostate, and positive in the epithelium and stromal
cells of both BPH and PC specimens. Immunostaining intensity in PC was sig
nificantly higher than in BPH. These observations suggest that the expressi
on of both mutant-p53 and c-myc, together with other factors, might be invo
lved in the development of prostatic hyperplasia and neoplasia, while the i
ncreased expression of IFN-gamma and its receptors could be regarded as an
attempt, although insufficient, to inhibit the uncontrolled cell proliferat
ion.